Effect of Wearable Devices and 5G-Powered Remote Precision Rehabilitation on Vascular Function in Post-PCI Patients: An Analysis of the Associations Between FMS, Cardiorespiratory Fitness, and Arterial Stiffness.
Yuping Long, Tao Xu, Zonghua Xiong et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial investigated the impact of 5G-powered remote rehabilitation on vascular function in 155 post-PCI patients. Over 12 months, the 5G group showed significant improvements in left ventricular ejection fraction (LVEF), E/e', left atrial diameter (LA), left ventricular end-diastolic diameter (LVEDD), Flow-Mediated Slowing (FMS), and carotid-femoral pulse wave velocity (cf-PWV) compared to the conventional group, with all results statistically significant (p < 0.05).
Key findings
- The 5G remote monitoring group showed significant improvements in LVEF, E/e', LA, LVEDD, FMS, and cf-PWV compared to the traditional group (all p < 0.05).
- Improvements in LDL-C in the traditional group were superior to those in the 5G remote monitoring group (p < 0.05).
- Peak VO2 was positively correlated with left ventricular ejection fraction (LVEF) (r > 0.4).
- The Gini index ranking indicated that cf-PWV, LVEF, age, peak VO2, and Peak WR significantly impacted FMS.
Why it matters
The findings suggest that integrating 5G technology into rehabilitation programs can enhance vascular recovery and exercise compliance in post-PCI patients, potentially leading to better long-term outcomes.